Dongwha Pharm.Co.,Ltd signed an agreement to acquire 51% stake in TRUNGSONCARE CO., LTD for $30 million.
August 03, 2023
Share
Dongwha Pharm.Co.,Ltd (KOSE:A000020) signed an agreement to acquire 51% stake in TRUNGSONCARE CO., LTD for $30 million on August 3, 2023. Locus Capital Partners acted as due diligence provider to Dongwha Pharm.Co.,Ltd.
DONGWHA PHARM.CO., LTD is a Korea-based company engaged in the manufacture of pharmaceuticals. The Companyâs products consist of ethical drugs, including digestive system remedies, antibiotics, cardiovascular and metabolic disease treatments, non steroidal anti-inflammatory drugs, respiratory remedies, muscle relaxants, nervous system remedies, dermatological remedies and urinary system remedies, and over-the-counter (OTC) drugs, including cold remedies, dental remedies, dermatological remedies, hepatic protectors, nutrients, tonics, topical analgesics, anti-smoking agents and others. It also provides medicine raw materials, health food and drinks, as well as cosmetics. The Company distributes its products within domestic market and to overseas markets.
DONGWHA PHARM.CO.,LTD 
